Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity

A composition and drug technology, applied in the direction of drug combination, application, bacteria, etc., can solve problems such as patient exposure, and achieve the effect of minimizing side effects

Inactive Publication Date: 2015-12-16
G·莫格纳
View PDF3 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, it is inconceivable to continue dru...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity
  • Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity
  • Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] The subject of the present invention is therefore a composition having the characteristics described in the appended independent claims.

[0023] Further preferred embodiments of the invention are described below and are claimed in the appended dependent claims.

[0024] Table 1 shows by way of example a group of microorganisms which are effectively used in the context of the present invention.

[0025] The applicant has carried out in-depth research and screening activities, and finally found that it belongs to the group selected from the group consisting of Lactobacillus acidophilus (L.acidophilus), Lactobacillus crispatus (L.crispatus), Lactobacillus gasseri (L.gasseri), Lactobacillus delbrueckii Bacillus (L.delbrueckii), Lactobacillus salivarius (L.salivarius), Lactobacillus casei (L.casei), Lactobacillus paracasei (L.paracasei), Lactobacillus plantarum (L.plantarum), Lactobacillus rhamnosus ( L.rhamnosus), Lactobacillus reuteri (L.reuteri), Lactobacillus brevis (L...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a composition comprising probiotic bacteria for use in the pharmacological treatment of gastric hyperacidity. Said composition is capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity and of minimizing the secondary effects due to said pharmacological treatment.

Description

technical field [0001] The present invention relates to a composition comprising probiotics for use in the medical treatment of hyperacidity. The composition is capable of restoring the barrier effect of the stomach lost during drug treatment of hyperchlorhydria and minimizing side effects due to the drug treatment. Background technique [0002] Over the past few decades, various pharmacological approaches have been developed for the drug treatment of hyperacidity which, if in exacerbated form and prolonged, can cause various complications or pathologies such as peptic ulcer and gastroesophageal reflux disease. [0003] Among the most widely used drugs are those based on the ability to inhibit histamine H 2 Those whose active ingredients are receptor inhibitors, such as cimetidine, famotidine, nizatidine, and ranitidine, etc., or those based on active ingredients that inhibit prostaglandins, such as misoprostol, etc. . Another class of drugs is based on active ingredient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K35/747A61K35/745A61K35/744A23L1/29A61K45/06A61P1/04C12R1/225A23L33/00A61K35/74
CPCA23V2002/00A61K35/74A61K45/06C12N1/20A23L33/135A61K35/745A61P1/04A61P1/14C12R2001/23C12N1/205C12R2001/225C12R2001/25C12R2001/01C12R2001/46A61K2300/00A23V2200/3204A61K35/747
Inventor G·莫格纳
Owner G·莫格纳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products